Mason Street Advisors’s Accendra Health ACH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-27,413
| Closed | -$742K | – | 864 |
|
|
2020
Q4 | $742K | Buy |
27,413
+3,484
| +15% | +$89.6K | 0.01% | 1046 |
|
|
2020
Q3 | $601K | Buy |
23,929
+274
| +1% | +$4K | 0.01% | 1023 |
|
|
2020
Q2 | $180K | Buy |
23,655
+1,763
| +8% | +$12.9K | ﹤0.01% | 1364 |
|
|
2020
Q1 | $200K | Hold |
21,892
| – | – | ﹤0.01% | 1273 |
|
|
2019
Q4 | $113K | Buy |
21,892
+514
| +2% | +$3.3K | ﹤0.01% | 1472 |
|
|
2019
Q3 | $124K | Buy |
21,378
+370
| +2% | +$1.66K | ﹤0.01% | 1448 |
|
|
2019
Q2 | $67K | Buy |
21,008
+1,010
| +5% | +$3.44K | ﹤0.01% | 1494 |
|
|
2019
Q1 | $82K | Buy |
19,998
+660
| +3% | +$4.17K | ﹤0.01% | 1538 |
|
|
2018
Q4 | $122K | Buy |
19,338
+873
| +5% | +$9.06K | ﹤0.01% | 1428 |
|
|
2018
Q3 | $305K | Buy |
18,465
+621
| +3% | +$10.6K | 0.01% | 1260 |
|
|
2018
Q2 | $298K | Buy |
17,844
+779
| +5% | +$12.6K | 0.01% | 1258 |
|
|
2018
Q1 | $265K | Sell |
17,065
-13,111
| -43% | -$234K | 0.01% | 1257 |
|
|
2017
Q4 | $570K | Sell |
30,176
-213
| -0.7% | -$4.72K | 0.01% | 991 |
|
|
2017
Q3 | $887K | Buy |
30,389
+492
| +2% | +$14.5K | 0.02% | 862 |
|
|
2017
Q2 | $962K | Buy |
29,897
+1,062
| +4% | +$34.9K | 0.02% | 826 |
|
|
2017
Q1 | $998K | Buy |
28,835
+128
| +0.4% | +$4.57K | 0.03% | 812 |
|
|
2016
Q4 | $1.01M | Sell |
28,707
-168
| -0.6% | -$5.68K | 0.03% | 795 |
|
|
2016
Q3 | $1M | Buy |
28,875
+239
| +0.8% | +$8.37K | 0.03% | 778 |
|
|
2016
Q2 | $1.07M | Buy |
28,636
+1,342
| +5% | +$50.4K | 0.03% | 724 |
|
|
2016
Q1 | $1.1M | Buy |
27,294
+955
| +4% | +$35.6K | 0.03% | 702 |
|
|
2015
Q4 | $948K | Buy |
26,339
+425
| +2% | +$15.4K | 0.03% | 734 |
|
|
2015
Q3 | $828K | Buy |
25,914
+325
| +1% | +$11.1K | 0.03% | 766 |
|
|
2015
Q2 | $870K | Buy |
25,589
+191
| +0.8% | +$6.43K | 0.03% | 796 |
|
|
2015
Q1 | $859K | Buy |
25,398
+730
| +3% | +$25.4K | 0.03% | 801 |
|
|
2014
Q4 | $866K | Sell |
24,668
-83
| -0.3% | -$2.79K | 0.01% | 1229 |
|
|
2014
Q3 | $810K | Buy |
24,751
+247
| +1% | +$8.41K | 0.01% | 1238 |
|
|
2014
Q2 | $833K | Sell |
24,504
-618
| -2% | -$21.2K | 0.01% | 1229 |
|
|
2014
Q1 | $880K | Buy |
25,122
+122
| +0.5% | +$4.3K | 0.01% | 1210 |
|
|
2013
Q4 | $914K | Sell |
25,000
-160
| -0.6% | -$5.87K | 0.01% | 1199 |
|
|
2013
Q3 | $870K | Sell |
25,160
-162,350
| -87% | -$5.68M | 0.01% | 998 |
|
|
2013
Q2 | $6.34M | Buy |
+187,510
| New | +$6.22M | 0.07% | 315 |
|
Other funds holding ACH
DM
Mason Street Advisors's ACH Position: Q1 2021 in Review
Mason Street Advisors sold out of Accendra Health (ACH) in Q1 2021, closing a stake of 27,413 shares — an estimated $742K sold.
Mason Street Advisors first reported a position in ACH in Q2 2013 and held it in 31 quarters. The position peaked at $6.34M in Q2 2013. 253 funds tracked by Wall St. Rank hold ACH as of Q1 2021.
- Mason Street Advisors reported no remaining Accendra Health position as of Q1 2021 after selling out during the quarter.
- Mason Street Advisors sold 27,413 Accendra Health shares in Q1 2021, an estimated $742K.
- Mason Street Advisors first reported a position in Accendra Health in Q2 2013 and held it in 31 quarters.
- Mason Street Advisors's Accendra Health position peaked at $6.34M in Q2 2013.
- 253 funds tracked by Wall St. Rank held Accendra Health as of Q1 2021.
Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.